Last updated on August 2020

Anti-Androgen Treatment for COVID-19


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Recurrent | Prostate Cancer | Benign Prostatic Hyperplasia (Enlarged Prostate) | SARS coronavirus | Prostatic disorder | Covid-19 | Severe Acute Respiratory Syndrome | Early | Prostate Disorders | Hair Loss | *COVID-19 | Alopecia | Benign prostatic hypertrophy | SARS-CoV2 | Male Pattern Baldness | Malignant neoplasm of prostate
  • Age: Between 50 - 100 Years
  • Gender: Male

Inclusion Criteria:

  1. Male
  2. Age 50 years old
  3. Presenting "Gabrin sign" i.e., androgenetic alopecia (Norwood-Hamilton grade III)
  4. Positive SARS-CoV-2 rtPCR test in the past 7 days
  5. Not hospitalized for acute respiratory symptoms
  6. Willing to provide informed consent

Exclusion Criteria:

  1. Subject enrolled in a study to investigate a COVID-19 drug
  2. Subject taking an anti-androgen
  3. Hypothyroidism
  4. Not willing to provide informed consent

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.